このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit

2022年2月1日 更新者:Mikhail Dziadzko, MD, PhD

Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit - a Multicenter Observational Cohort Study

More than six million French were affected by SARS-COV2 epidemic. About 20% of infected peoples were hospitalized, and about 5% were admitted to the intensive care units (ICU) for severe SARS-COV2 acute respiratory distress syndrome (ARDS) management.

A spectrum of neuropsychiatric sequelae, specific for the ICU exposure, was already described, including post-intensive care syndrome and persistent pain.

A growing body of evidence suggests the impact of SARS-COV2 exposure on the occurrence of neurological disorders and chronic pain syndrome development in COVID-19 patients.

Taking together, one can expect a large number of patients discharged from ICU after severe COVID-19 with high prevalence of persistent pain and psychological disorders. To date, no study has evaluated neither the incidence of persistant pains in ICU COVID-19 survivors, nor pain phenotypes.

The knowledge of such data is crucial in order to anticipate the management of such patients by specialized pain team, and to quantify the possible incurred burden of care.

Our study aims to evaluate the incidence of pain, pain localization and severity, associated pain-related psychological disorders, and to perform quantitative sensory testing in severe COVID-19 patients, admitted to the ICU for more than 48 hours and successfully discharged home during the first French pandemic wave.

調査の概要

研究の種類

観察的

入学 (実際)

143

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Le Kremlin-Bicêtre、フランス、Le Kremlin-Bicêtre
        • Hôpital Bicêtre AP-HP
      • Lyon、フランス、69004
        • Hôpital de la croix Rousse - Hospices Civils de Lyon
    • Hauts-de-Seine
      • Garches、Hauts-de-Seine、フランス、92380
        • Hôpital Raymond Poincaré - AP-HP

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

adult patients, infected with SARS COV2 and developed severe COVID, requiring hospitalisation to the ICU during the first French wave of COVID 19, with length of stay > 48 hours, survived and successfully discharged, and approached from 6th month post discharge.

説明

Inclusion Criteria:

  • adults (>=18 y.o.)
  • hospitalized in the ICU for at least 48 hours
  • with SARS-Cov2 infection confirmed by Polymerase Chain Reaction (PCR)/serology and/or a suggestive chest Computed Tomography scan
  • during the first wave of COVID 19 from March to December 2020 at three investigator sites (2 in Paris and 1 in Lyon)
  • discharged alive from the ICU
  • at least 6 months after discharge

Exclusion Criteria:

  • patient refusal
  • inability to communicate or to have in-person appointment
  • death in the period from ICU discharge to the first phone call for interview

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:コホート
  • 時間の展望:断面図

コホートと介入

グループ/コホート
介入・治療
post COVID-19 ICU survivors
Patients hospitalized to the ICU in the context of severe COVID-19 and discharged alive during the first French COVID-19 pandemic wave
Patient-reported outcomes, listed in the Secondary Outcome Measure Section
Summation pain threshold test and Heat pain threshold skin test

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Incidence of secondary chronic pain
時間枠:starting 6 month after discharge

Secondary chronic pain as defined by International Classification of Disease -11th revision (ICD-11).

Chronic secondary pain is organized into the following six categories:

  1. Chronic cancer-related pain (ICD-11 code MG30.1)
  2. Chronic postsurgical or post-traumatic pain (ICD-11 code MG30.2)
  3. Chronic secondary musculoskeletal pain (ICD-11 code MG30.3)
  4. Chronic secondary visceral pain (ICD-11 code MG30.4)
  5. Chronic neuropathic pain (ICD-11 code MG30.5)
  6. Chronic secondary headache or orofacial pain (ICD-11 code MG30.6)

Any pain detected in the population of interest and fitting in one of 6 categories will be accounted.

starting 6 month after discharge

二次結果の測定

結果測定
メジャーの説明
時間枠
Frequency of different secondary chronic pain classes
時間枠:starting 6 month after discharge

as defined by ICD-11 and the International Association for the Study of Pain (IASP)

Chronic secondary pain is organized into the following six categories:

  1. Chronic cancer-related pain (ICD-11 code MG30.1)
  2. Chronic postsurgical or post-traumatic pain (ICD-11 code MG30.2)
  3. Chronic secondary musculoskeletal pain (ICD-11 code MG30.3)
  4. Chronic secondary visceral pain (ICD-11 code MG30.4)
  5. Chronic neuropathic pain (ICD-11 code MG30.5)
  6. Chronic secondary headache or orofacial pain (ICD-11 code MG30.6)

For each category of detected pain the frequency will be reported.

starting 6 month after discharge
Pain sensitivity level
時間枠:starting 6 month after discharge
Pain sensitivity level is tested with a Pain sensitivity questionnaire (PSQ). PSQ contains 17 items assessing pain with 11 level scoring from 0 (not at all painful) to 10 (most severe pain imaginable). Maximal summation score is 170, higher score mean worse outcome.
starting 6 month after discharge
Pain localization
時間枠:starting 6 month after discharge
A Michigan Body Map will be used for pain localization inventory. A Michigan Body Map is a self-report measure to assess body areas where chronic pain is experienced.
starting 6 month after discharge
The severity of pain and its impact on functioning
時間枠:starting 6 month after discharge
A Brief Pain Inventory (BPI) will be used to assess the severity of pain and its impact on functioning. The BPI pain scales defines pain as follows: Worst Pain Score: 1 - 4 = Mild Pain. Worst Pain Score: 5 - 6 = Moderate Pain. Worst Pain Score: 7 - 10 = Severe Pain. BPI Interference Items use 0 (less) to 10 (worth) scoring, the arithmetic mean of the interference items is used as a measure of pain interference, higher score mean worse outcome.
starting 6 month after discharge
Neuropathic pain
時間枠:starting 6 month after discharge
A DN4 scale will be used to detect a neuropathic pain. The DN4 (which stands for Douleur Neuropathique 4) is a clinician-administered questionnaire consisting of 10 items. Seven items related to pain quality (i.e. sensory and pain descriptors) are based on an interview with the patient and 3 items based on the clinical examination. Each item has binary value (yes/no), maximal summation score is 10, and the threshold for neuropathic pain is 4.
starting 6 month after discharge
Spiegel Sleep Quality Questionnaire
時間枠:starting 6 month after discharge
Spiegel Sleep Questionnaire is a self-rated questionnaire which assesses the current sleep quality and disturbances. It has six 5 point Likert-like items rated from worst to best value. The total summation score is 30, less score values indicates worth outcome. The threshold of bad sleep is less than 15, and the score 20 indicates a good sleep.
starting 6 month after discharge
Posttraumatic Stress Disorder
時間枠:starting 6 month after discharge

Posttraumatic Stress Disorder Checklist Scale is a 20-item self-report measure that assesses the symptoms of Posttraumatic Stress Disorder. Respondents rate each item from 0 ("not at all") to 4 ("extremely") to indicate the degree to which they have been bothered by that particular symptom over the past month.

A total symptom severity score is obtained by summing the scores for each of the 20 items. The score superior of 31 is indicative of probable Posttraumatic Stress Disorder.

starting 6 month after discharge
Anxiety and Depression
時間枠:starting 6 month after discharge

Hospital Anxiety Depression scale will be used, it measures anxiety and depression in a general medical population of patients. The questionnaire comprises seven questions for anxiety and seven questions for depression. Greater score values indicates worth outcome.

For both scales, scores of less than 7 indicate non-cases; 8-10 - mild depression or anxiety; 11-14 - moderate depression or anxiety; and 15-21 - severe depression or anxiety.

starting 6 month after discharge
Pain Catastrophizing Level
時間枠:starting 6 month after discharge
Pain Catastrophizing Scale quantifies an individual's pain experience. It has 13 items rated on 5-point Likert-like scales (0 - not at all to 4 - all the time). A total score is yielded (ranging from 0-52), the threshold above 30 is considered clinically relevant. Higher score indicates higher level of catastrophizing and bad outcome.
starting 6 month after discharge
Perceived Stress Level
時間枠:starting 6 month after discharge
Perceived Stress Scale (PSS-10) is a self stress assessment instrument. It has 10 items rated on 5-point Likert-like scales (0 - never to 4 - very often). Individual scores on the PSS-10 can range from 0 to 40 with higher scores indicating higher perceived stress.
starting 6 month after discharge
Summation pain threshold
時間枠:starting 6 month after discharge
Mechanical temporal summation will be evoked using methodology described by Weissman-Fogel, 2008, by Von Frey Filaments, using a 180-gr filament that will be applied to the volar aspect of the dominant forearm. Patients will be exposed to a single stimulus and will be asked to rate the level of pinprick pain intensity using 11 items numeric pain scale. This pain score serve as an index for mechanical suprathreshold pain. Subsequently, 1 Hz repetitive stimuli will be applied within an area of 1 cm in diameter, using the same filament, and subjects will be asked to rate the pain intensity of the last stimulus. The magnitude of mechanical temporal summation will be calculated as the difference between the last and the first pain scores. Higher values indicates worth outcome.
starting 6 month after discharge
Heat pain threshold
時間枠:starting 6 month after discharge
A heat pain threshold will be realized using Thermal Stimulator for Sensory testing (SOMEDIC(R)). A thermode (heating stick) of 7 square centimeters will be applied to the volar aspect of the dominant forearm. Patients will be exposed to 3 repetitive gradual increase in temperature from 32° to 52°C. The skin contact will be withdrawn if an individual is not able to tolerate such stimulation, and the temperature threshold of tolerance will be noted. The final reading will be the median of three measurements, higher values indicate better tolerance.
starting 6 month after discharge

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2021年1月11日

一次修了 (実際)

2022年1月1日

研究の完了 (実際)

2022年2月1日

試験登録日

最初に提出

2021年6月21日

QC基準を満たした最初の提出物

2021年6月23日

最初の投稿 (実際)

2021年6月25日

学習記録の更新

投稿された最後の更新 (実際)

2022年2月2日

QC基準を満たした最後の更新が送信されました

2022年2月1日

最終確認日

2022年2月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

individual participant data are the property of investigator's centers and will not be shared

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する